Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

Giselle V. Ripoll,Marina Pifano,Juan Garona,Daniel F. Alonso

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

2020

Giselle V. Ripoll
Marina Pifano
Juan Garona
Daniel F. Alonso

Fil: Ripoll, Giselle Vanina. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnologia. Laboratorio de Oncologia Molecular; Argentina. Consejo Nacional de Investigaciones Cientificas y Tecnicas; Argentina

Keywords:

Cancer research
Immunology
Prostate cancer
Castration
Arginine vasopressin receptor 1A
Medicine
Pharmacology
Relcovaptan
Vasopressin
Drug repositioning
Desmopressin
castration resistant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations